X4 Pharmaceuticals, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-22.0M | $-23.0M |
| Depreciation & Amortization | $71.0K | $285.0K |
| Depreciation | — | — |
| Amortization | — | — |
| Stock-Based Compensation | $492.0K | $644.0K |
| Net Cash from Operating Activities | $-21.3M | $-21.6M |
| Investing Activities | ||
| Capital Expenditures | $378.0K | $73.0K |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $-378.0K | $-73.0K |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $33.4M | $18.1M |
| Net Change in Cash | $11.7M | $-3.7M |
| Free Cash Flow | $-21.7M | $-21.7M |